Gang Zeng resumes & CV records
Resumes
Gang Zeng
Gang Zeng, 47Cupertino, CA
Gang Zeng Phones & Addresses
Cupertino, CA
Santa Clara, CA
Arcadia, CA
Chicago, IL
West Covina, CA
Work
Company:
University of california, los angeles
Address:
405 Hilgard Ave, Los Angeles, CA 90095
Phones:
310-8254321
Position:
Assistant adjunct professor in rsdn urology
Industries:
Colleges, Universities, and Professional Schools
Mentions for Gang Zeng
Publications & IP owners
Us Patents
Dominant B Cell Epitopes And Methods Of Making And Using Thereof
US Patent:
7943729, May 17, 2011
Filed:
Jul 30, 2008
Appl. No.:
12/182652
Inventors:
Gang Zeng - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
National Institutes of Health - Rockville MD
National Institutes of Health - Rockville MD
International Classification:
A61K 38/00
G01N 33/53
G01N 33/53
US Classification:
530300, 435 71
Abstract:
Disclosed are methods for obtaining at least one epitope suitable for detecting the presence of an antibody against a tumor associated antigen of a cancer in a sample. Kits, assays, and substrates employing the epitopes of the present invention are disclosed. Also disclosed are epitopes of NY-ESO-1 and XAGE-1b and methods of using thereof.
Dominant B Cell Epitopes And Methods Of Making And Using Thereof
US Patent:
2007020, Aug 30, 2007
Filed:
May 19, 2005
Appl. No.:
11/569250
Inventors:
Gang Zeng - Los Angeles CA, US
International Classification:
G01N 33/574
C07K 16/30
C07K 16/30
US Classification:
435007230, 530388800
Abstract:
Disclosed are methods for obtaining at least one epitope suitable for detecting the presence of an antibody against a tumor associated antigen of a cancer in a sample. Kits, assays, and substrates employing the epitopes of the present invention are disclosed. Also disclosed are epitopes of NY-ESO-1 and XAGE-1b and methods of using thereof.
A+ Biomarker Assays
US Patent:
2011031, Dec 22, 2011
Filed:
Feb 19, 2010
Appl. No.:
13/141525
Inventors:
Gang Zeng - Los Angeles CA, US
International Classification:
G01N 33/53
US Classification:
435 792, 436501
Abstract:
Disclosed herein assay methods which comprise detecting the presence, absence or amount of at least one antibody which specifically binds a first biomarker or an epitope thereof and at least one second biomarker in a sample which comprises a single reaction step whereby both a first capture reagent for the antibody and a second capture reagent for the second biomarker are together contacted with the sample, and detecting the presence, absence or amount of the antibody, and detecting the presence, absence or amount of the second biomarker. Also disclosed are assay methods for prostate cancer.
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.